Abstract: A method, apparatus, and computer instructions for sending content from a first application to a second application. In response to a user input indicating a selection of content for transfer to the second application, the selection of the content is copied to form copied content. The copied content is then automatically sent to the second application without requiring additional user manipulation of the copy content. Additionally, the destination may be another user. In this case, the second application is employed to automatically transfer the copied content to that second user.

Abstract: An ignition timing circuit is disclosed which provides variable fuel ignition timing as a function of the rotational speed of a small internal combustion engine. A measure of the rotational speed of an engine is generated from the shape of pulses generated by a sensor. A timing delay circuit converts this measure of the rotational engine speed into a fuel ignition trigger signal with a controlled delay relative to the engine's angular position. This trigger signal activates a switching device which in turn delivers energy to the engine's spark plug system. A significant benefit of the disclosed ignition timing circuit is its ability to be enclosed in a package which is size and pin-compatible with standard silicon controlled rectifiers.

Abstract: A computer-implemented method, apparatus, and computer program product for managing rejected messages. Metadata is extracted from a message for storing information about the message in response to the message being rejected. The metadata is saved in an entry in a file. The file may be examined to identify the rejected messages. An intended recipient is notified of a rejection using the metadata.

Abstract: A computer-implemented method, apparatus, and computer program product for managing rejected messages. Metadata is extracted from a message for storing information about the message in response to the message being rejected based on a problem on an email server. The metadata includes an identification of the problem on the email server and an email identification. A failure notification is sent to a sending party. The failure notification includes the metadata and indicates that a problem has occurred on an email server causing the message to be rejected. A correction notification is sent based on correction notification preferences in response to correction of the message problem. The correction notification includes the metadata and indicates that the problem on the email server has been corrected.

Abstract: A computer-implemented method, apparatus, and computer program product for resending a message based on server status. The message is sent to a recipient. The message is stored to be resent in response to receiving a notification that the message could not be delivered to the recipient. Status of an email server associated with the recipient of the message is requested. The message is resent in response to the status indicating that messages may be received by the recipient.

Abstract: A method of reducing or inhibiting kinase activity of C-KIT in a cell or a subject, and the use of such compounds for preventing or treating in a subject a cell proliferative disorder and/or disorders related to C-KIT using a compound of the present invention: or a solvate, hydrate, tautomer or pharmaceutically acceptable salt thereof. The present invention is further directed to methods for treating conditions such as cancers and other cell proliferative disorders.

Abstract: The invention is directed to compounds of Formula I: wherein Z, X, J, R2 and W are set forth in the specification, as well as solvates, hydrates, tautomers and pharmaceutically acceptable salts thereof, that inhibit protein tyrosine kinases, especially c-fms kinase. Methods of treating autoimmune diseases; and diseases with an inflammatory component; treating metastasis from ovarian cancer, uterine cancer, breast cancer, prostate cancer, lung cancer, colon cancer, stomach cancer, hairy cell leukemia; and treating pain, including skeletal pain caused by tumor metastasis or osteoarthritis, or visceral, inflammatory, and neurogenic pain; as well as osteoporosis, Paget's disease, and other diseases in which bone resorption mediates morbidity including rheumatoid arthritis, and other forms of inflammatory arthritis, osteoarthritis, prosthesis failure, osteolytic sarcoma, myeloma, and tumor metastasis to bone with the compounds of Formula I, are also provided.

Abstract: The invention is directed to compounds of Formula I: wherein Z, X, J, R2 and W are set forth in the specification, as well as solvates, hydrates, tautomers and pharmaceutically acceptable salts thereof, that inhibit protein tyrosine kinases, especially c-fms kinase. Methods of treating autoimmune diseases; and diseases with an inflammatory component; treating metastasis from ovarian cancer, uterine cancer, breast cancer, prostate cancer, lung cancer, colon cancer, stomach cancer, hairy cell leukemia; and treating pain, including skeletal pain caused by tumor metastasis or osteoarthritis, or visceral, inflammatory, and neurogenic pain; as well as osteoporosis, Paget's disease, and other diseases in which bone resorption mediates morbidity including rheumatoid arthritis, and other forms of inflammatory arthritis, osteoarthritis, prosthesis failure, osteolytic sarcoma, myeloma, and tumor metastasis to bone with the compounds of Formula I, are also provided.

Abstract: The invention is directed to compounds of Formula I: wherein Z, X, J, R2 and W are set forth in the specification, as well as solvates, hydrates, tautomers and pharmaceutically acceptable salts thereof, that inhibit protein tyrosine kinases, especially c-fms kinase. Methods of treating autoimmune diseases; and diseases with an inflammatory component; treating metastasis from ovarian cancer, uterine cancer, breast cancer, prostate cancer, lung cancer, colon cancer, stomach cancer, hairy cell leukemia; and treating pain, including skeletal pain caused by tumor metastasis or osteoarthritis, or visceral, inflammatory, and neurogenic pain; as well as osteoporosis, Paget's disease, and other diseases in which bone resorption mediates morbidity including rheumatoid arthritis, and other forms of inflammatory arthritis, osteoarthritis, prosthesis failure, osteolytic sarcoma, myeloma, and tumor metastasis to bone with the compounds of Formula I, are also provided.

Abstract: The invention is directed to compounds of Formula I: wherein Z, X, J, R2 and W are set forth in the specification, as well as solvates, hydrates, tautomers and pharmaceutically acceptable salts thereof, that inhibit protein tyrosine kinases, especially c-fms kinase. Methods of treating autoimmune diseases; and diseases with an inflammatory component; treating metastasis from ovarian cancer, uterine cancer, breast cancer, colon cancer, stomach cancer, hairy cell leukemia and non-small lung carcinoma; and treating pain, including skeletal pain caused by tumor metastasis or osteoarthritis, or visceral, inflammatory, and neurogenic pain; as well as osteoporosis, Paget's disease, and other diseases in which bone resorption mediates morbidity including arthritis, prosthesis failure, osteolytic sarcoma, myeloma, and tumor metastasis to bone with the compounds of Formula I, are also provided.

Abstract: The invention is directed to compounds of Formula I: wherein Z, X, J, R2 and W are set forth in the specification, as well as solvates, hydrates, tautomers and pharmaceutically acceptable salts thereof, that inhibit protein tyrosine kinases, especially c-fms kinase. Methods of treating autoimmune diseases; and diseases with an inflammatory component; treating metastasis from ovarian cancer, uterine cancer, breast cancer, prostate cancer, lung cancer, colon cancer, stomach cancer, hairy cell leukemia; and treating pain, including skeletal pain caused by tumor metastasis or osteoarthritis, or visceral, inflammatory, and neurogenic pain; as well as osteoporosis, Paget's disease, and other diseases in which bone resorption mediates morbidity including rheumatoid arthritis, and other forms of inflammatory arthritis, osteoarthritis, prosthesis failure, osteolytic sarcoma, myeloma, and tumor metastasis to bone with the compounds of Formula I, are also provided.

Abstract: A method of operating a computer to facilitate a commercial transaction involving a plurality of negotiable trading parameters.

Abstract: A comprehensive method for handling telephone calls directed to a telephone number of a terminated user that has been reassigned to a new user. The present invention provides user with a notification service that intercepts telephone calls to said telephone number and notifies callers that the telephone number has been reassigned to the new user. Callers seeking the new user continue calls to user, which results in user only being alerted by continuing callers and not being bothered by callers seeking the terminated user. The user can customize the notification message to inform callers of the details regarding the telephone number reassignment and to whom the telephone number was reassigned. The user can specify a time period for the notification service to be activated. The notification service stores all continuing calls in a log, and bypasses all subsequent calls from telephone numbers listed in the log.

Abstract: A method of reducing or inhibiting kinase activity of FLT3 in a cell or a subject, and the use of such compounds for preventing or treating in a subject a cell proliferative disorder and/or disorders related to FLT3 using a ompound of the present invention: or a solvate, hydrate, tautomer or pharmaceutically acceptable salt thereof. The present invention is further directed to methods for treating conditions such as cancers and other cell proliferative disorders.

Abstract: Telephone information stored in the wireless communication device is automatically updated when a dialed telephone number has changed. Upon receiving an error code in response to making a call, the cell phone automatically determines if the error code indicates that the dialed telephone number has changed to a new telephone number. If so, the cell phone automatically determines the new telephone number from the error code and automatically updates a phone book contained within the cell phone with the new telephone number.

Abstract: A method of facilitating an e-commerce transaction, the method including: providing a set of trading parameters; accepting in respect of a first entity (3) a desired trading profile including desired values or ranges of multiple of said trading parameters; and accepting in respect of said first entity (3) one or more further trading profiles including values or ranges of multiple of said trading parameters; establishing one or more functional relationships between variations in a key trading parameter and one or more other of said trading parameters; wherein each of said further trading profiles are equivalent in desirability or expected value to said desired trading profile, and said functional relationship can be used to determine a set of equivalent trading profiles having substantially desirability equal expected values equivalent to said desired trading profile and said further trading profiles.

Abstract: The invention is directed to compounds of Formula I: wherein A, X, R2 and W are set forth in the specification, as well as solvates, hydrates, tautomers and pharmaceutically acceptable salts thereof, that inhibit protein tyrosine kinases, especially c-fms kinase. Methods of treating autoimmune diseases; and diseases with an inflammatory component; treating metastasis from ovarian cancer, uterine cancer, breast cancer, colon cancer, stomach cancer, hairy cell leukemia and non-small lung carcinoma; and treating pain, including skeletal pain caused by tumor metastasis or osteoarthritis, or visceral, inflammatory, and neurogenic pain; as well as osteoporosis, Paget's disease, and other diseases in which bone resorption mediates morbidity including arthritis, prosthesis failure, osteolytic sarcoma, myeloma, and tumor metastasis to bone with the compounds of Formula I, are also provided.

Abstract: Plant protection devices, kits, and methods of protecting plants during adverse conditions are provided. The plant protection devices can have a enclosure and/or a precipitation member assembly. The plant protection devices can provide wind protection, mulch retention, and precipitation deflection.

Abstract: The invention relates to compounds of Formula I: wherein A, X, R2 and W are set forth in the specification, as well as solvates, hydrates, tautomers and pharmaceutically acceptable salts thereof, that inhibit protein tyrosine kinases, especially c-fms kinase. Methods of treating autoimmune diseases; and diseases with an inflammatory component; treating metastasis from ovarian cancer, uterine cancer, breast cancer, colon cancer, stomach cancer, hairy cell leukemia and non-small lung carcinoma; and treating pain, including skeletal pain caused by tumor metastasis or osteoarthritis, or visceral, inflammatory, and neurogenic pain; as well as osteoporosis, Paget's disease, and other diseases in which bone resorption mediates morbidity including arthritis, prosthesis failure, osteolytic sarcoma, myeloma, and tumor metastasis to bone with the compounds of Formula I, are also provided.

Abstract: Disclosed is a method for treating the symptoms of an acute or chronic disorder mediated by the classical pathway of the complement cascade, comprising administering to a mammal in need of such treatment a therapeutically effective amount of a compound of Formula (I) or a solvate, hydrate or pharmaceutically acceptable salt thereof; wherein R1, R2, R3, R4 and R7 are defined in the specification, Z is SO or SO2, and Ar is an aromatic or heteroaromatic group as defined herein.